Graft-versus-host disease is one of the main causes of morbidity and mortality in patients submitted to hematopoietic stem cell transplantation. This study reviewed the prevalence of lower female genital tract graft-versus-host disease following hematopoietic stem cell transplantation. A systematic search of the literature for articles published between 1982 and 2015 was performed. A growing number of young women suffering from malignant and benign hematological diseases are receiving allogeneic hematopoietic stem cell transplantation with very satisfactory results in relation to the disease itself. However, these patients face gynecological problems due to graft-versus-host disease. Correct diagnosis and early management are needed to avoi...
AbstractWe describe a series of women after allogeneic stem cell transplantation with vaginal graft-...
ABSTRACT graft-versus-host disease (GVHD) is one of the main complications of hematopoietic stem cel...
In 1963 George Mathé announced to the world that he had cured a patient of leukaemia by means of a b...
AbstractUsing the National Institutes of Health (NIH) consensus criteria for chronic graft-versus-ho...
ABSTRACT BACKGROUND. Chronic graft-versus-host disease (cGvHD) is the major cause of morbidity afte...
Chronic graft-versus-host disease (cGVHD) is the most common late complication of allogeneic hematop...
Hematopoietic stem cell transplantation (HSCT) is a crucial treatment for hematological malignancy. ...
Introduction. After hematopoietic stem cell transplantation (HSCT), many patients present genital gr...
OBJECTIVES: Gynecological manifestation of chronic graft-versus-host disease (cGVHD) has been invari...
OBJECTIVES: Gynecological manifestation of chronic graft-versus-host disease (cGVHD) has been invari...
Objective: In patients receiving bone marrow transplantation (BMT), their mucosa becomes altered and...
OBJECTIVES: Gynecological manifestation of chronic graft-versus-host disease (cGVHD) has been invari...
AbstractWe describe a series of women after allogeneic stem cell transplantation with vaginal graft-...
ABSTRACT graft-versus-host disease (GVHD) is one of the main complications of hematopoietic stem cel...
In 1963 George Mathé announced to the world that he had cured a patient of leukaemia by means of a b...
AbstractUsing the National Institutes of Health (NIH) consensus criteria for chronic graft-versus-ho...
ABSTRACT BACKGROUND. Chronic graft-versus-host disease (cGvHD) is the major cause of morbidity afte...
Chronic graft-versus-host disease (cGVHD) is the most common late complication of allogeneic hematop...
Hematopoietic stem cell transplantation (HSCT) is a crucial treatment for hematological malignancy. ...
Introduction. After hematopoietic stem cell transplantation (HSCT), many patients present genital gr...
OBJECTIVES: Gynecological manifestation of chronic graft-versus-host disease (cGVHD) has been invari...
OBJECTIVES: Gynecological manifestation of chronic graft-versus-host disease (cGVHD) has been invari...
Objective: In patients receiving bone marrow transplantation (BMT), their mucosa becomes altered and...
OBJECTIVES: Gynecological manifestation of chronic graft-versus-host disease (cGVHD) has been invari...
AbstractWe describe a series of women after allogeneic stem cell transplantation with vaginal graft-...
ABSTRACT graft-versus-host disease (GVHD) is one of the main complications of hematopoietic stem cel...
In 1963 George Mathé announced to the world that he had cured a patient of leukaemia by means of a b...